查看購物車
  • Simplified Chinese
  • English
  • Japanese
全球口服補液 (ORS) 市場研究報告 - 2023 年至 2030 年行業分析、規模、佔有率、成長、趨勢和預測
市場調查報告書
商品編碼
1342825

全球口服補液 (ORS) 市場研究報告 - 2023 年至 2030 年行業分析、規模、佔有率、成長、趨勢和預測

Global Oral Rehydration Solution (ORS) Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 220 Pages | 商品交期: 最快1-2個工作天內

價格

全球口服補液溶液（ORS）市場需求預計將從2022年的5.77萬美元達到2030年近16.03萬美元的市場規模，2023-2030年研究期間年複合成長率為12.02%。

口服水合溶液是一種防止脫水的液體。患有腹瀉或嘔吐的患者會失去水分和電解質。口服補液將丟失的水分和電解質補充回體內，防止脫水。它通常由水和少量糖以及含有鈉和鉀的鹽組成。它還由鋅元素組成。口服補液可以直接攝入或通過鼻胃管給予。它有助於在各種病毒或細菌感染期間保持身體水分。

市場動態：

發展中國家的不潔淨水會導致腹瀉，從而導致對口服補液溶液的需求增加。口服補液鹽市場的兒科市場預計在未來幾年將成長最快。由於不健康和壓力大的生活方式，人們脫水的情況不斷增加，進一步增加了對口服補液解決方案的需求，從而導致市場成長。醫院患者和普通人群發病率和死亡率的上升增加了當地藥劑師對 ORS 的供應需求，直接推動了 OPRS 全球市場的發展。政府積極宣傳口服補液鹽的好處以及人們對口服補液鹽積極影響的認知，正在進一步推動其市場成長。

該研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球口服補液鹽 (ORS) 市場的各個細分市場進行了包容性評估。口服補液鹽行業的成長和趨勢為本研究提供了整體方法。

區域分析：

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲口服補液溶液市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。口服補液鹽 (ORS) 市場的主要參與者包括 FDC Limited、Cipla、Wallace Pharmaceuticals、Zydus Cadila Healthcare Ltd、Shereya Life Sciences、Mankind Pharma、Intas Pharmaceuticals Ltd.、Sun Pharma、Dr Reddy's、Alkem、Lupin、Cadila、 RPG生命科學，Casca Remedies Pvt。有限公司，哈爾伍德實驗室列兵。有限公司、Healthy Life Pharma Private Limited、Okasa Pharma Pvt.該部分包含競爭格局的整體視圖，包括各種戰略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第一章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法論
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：口服補液溶液 (ORS) - 行業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 行業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按產品銷售進行的市場吸引力分析
    • 按劑型分類的市場吸引力分析
    • 按客戶年齡分類的市場吸引力分析
    • 按指標進行的市場吸引力分析
    • 按配銷通路分類的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷管道發展趨勢

第 5 章：COVID-19 爆發的影響分析

第 6 章：全球口服補液 (ORS) 市場分析：按產品銷售

  • 按產品銷售情況概覽
  • 歷史和預測數據
  • 按產品銷量分析
  • 非處方藥產品
  • 處方

第 7 章：全球口服補液 (ORS) 市場分析：按劑型

  • 按劑型概述
  • 歷史和預測數據
  • 按劑型分析
  • 粉末
  • 液體
  • 藥片

第 8 章：全球口服補液溶液 (ORS) 市場分析：按客戶年齡

  • 按客戶年齡分類的概覽
  • 歷史和預測數據
  • 按顧客年齡分析
  • 孩子們
  • 成人

第 9 章：全球口服補液 (ORS) 市場分析：按適應症分類

  • 按適應症概述
  • 歷史和預測數據
  • 按指標分析
  • 腹瀉
  • 胃腸炎
  • 電解質不平衡
  • 其他

第 10 章：全球口服補液 (ORS) 市場分析：按配銷通路

  • 按配銷通路分類的概覽
  • 歷史和預測數據
  • 按配銷通路分析
  • 醫院藥房
  • 零售藥店
  • 網上藥店

第 11 章：全球口服補液溶液 (ORS) 市場分析：按地理位置

  • 頂級公司股票分析
  • 介紹
  • 北美銷售分析
    • 概述、歷史和預測銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家/地區銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概述、歷史和預測銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家/地區銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概述、歷史和預測銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區國家/地區銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳大利亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概述、歷史和預測銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家/地區銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概述、歷史和預測銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 12 章：口服補液 (ORS) 公司的競爭格局

  • 口服補液（Ors）市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 13 章：公司簡介

  • 公司股份分析
  • 市場集中度
  • FDC Limited
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Cipla
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Wallace Pharmaceuticals
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Zydus Cadila Healthcare Ltd
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Shereya Life Sciences
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Mankind Pharma
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Intas Pharmaceuticals Ltd.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Sun Pharma
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Dr Reddy's
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Alkem
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Lupin
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Cadila
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • RPG Life Sciences
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Casca Remedies Pvt. Ltd.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Halewood Laboratories Pvt. Ltd.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Healthy Life Pharma Private Limited
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Okasa Pharma Pvt. Ltd.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私營公司，則可能不包括在內

Product Code: VMR11219611

The global demand for Oral Rehydration Solution (ORS) Market is presumed to reach the market size of nearly USD 16.03 MN by 2030 from USD 5.77 MN in 2022 with a CAGR of 12.02% under the study period 2023 - 2030.

Oral hydration solution is a fluid that prevents dehydration. The patient suffering from diarrhoea or vomiting loses water and electrolytes. Oral rehydration solution replenishes that lost water and electrolytes back into the body, preventing dehydration. It usually consists of water with small amounts of sugars and salts containing sodium and potassium. It also consists of zinc elements. Oral rehydration solution can be ingested directly or given by a nasogastric tube. It helps to keep the body hydrated during various viral or bacterial infections.

MARKET DYNAMICS:

The presence of unclean water in developing countries causes diarrhoea which causes a rise in demand for oral rehydration solutions. The pediatric segment of the oral rehydration solution market is expected to grow the most in the upcoming years. The increasing cases of dehydration among people due to unhealthy and stressful lifestyles further increase the demand for Oral rehydration solutions, leading to market growth. Rising morbidity and mortality among hospital patients and the general population increase the ORS supply demand at local pharmacists, directly driving the OPRS global market. The active government campaigns about the ORS benefits and awareness among people about the positive impacts of ORS are further propelling its market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of oral rehydration solution (ORS). The growth and trends of oral rehydration solution industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the oral rehydration solution (ORS) market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Sales

  • OTC Products
  • Prescription

By Dosage Form

  • Powder
  • Liquid
  • Tablet

By Customer Age

  • Children
  • Adult

By Indication

  • Diarrhea
  • Gastroenteritis
  • Electrolyte Imbalance
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Oral Rehydration Solution market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the oral rehydration solution (ORS) market include FDC Limited, Cipla, Wallace Pharmaceuticals, Zydus Cadila Healthcare Ltd, Shereya Life Sciences, Mankind Pharma, Intas Pharmaceuticals Ltd., Sun Pharma, Dr Reddy's, Alkem, Lupin, Cadila, RPG Life Sciences, Casca Remedies Pvt. Ltd., Halewood Laboratories Pvt. Ltd., Healthy Life Pharma Private Limited, Okasa Pharma Pvt. Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . ORAL REHYDRATION SOLUTION (ORS) - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product Sales
    • 3.7.2 Market Attractiveness Analysis By Dosage Form
    • 3.7.3 Market Attractiveness Analysis By Customer Age
    • 3.7.4 Market Attractiveness Analysis By Indication
    • 3.7.5 Market Attractiveness Analysis By Distribution Channel
    • 3.7.6 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET ANALYSIS BY PRODUCT SALES

  • 6.1 Overview by Product Sales
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Product Sales
  • 6.4 OTC Products Historic and Forecast Sales by Regions
  • 6.5 Prescription Historic and Forecast Sales by Regions

7 . GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET ANALYSIS BY DOSAGE FORM

  • 7.1 Overview by Dosage Form
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Dosage Form
  • 7.4 Powder Historic and Forecast Sales by Regions
  • 7.5 Liquid Historic and Forecast Sales by Regions
  • 7.6 Tablet Historic and Forecast Sales by Regions

8 . GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET ANALYSIS BY CUSTOMER AGE

  • 8.1 Overview by Customer Age
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Customer Age
  • 8.4 Children Historic and Forecast Sales by Regions
  • 8.5 Adult Historic and Forecast Sales by Regions

9 . GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET ANALYSIS BY INDICATION

  • 9.1 Overview by Indication
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by Indication
  • 9.4 Diarrhea Historic and Forecast Sales by Regions
  • 9.5 Gastroenteritis Historic and Forecast Sales by Regions
  • 9.6 Electrolyte Imbalance Historic and Forecast Sales by Regions
  • 9.7 Others Historic and Forecast Sales by Regions

10 . GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 10.1 Overview by Distribution Channel
  • 10.2 Historical and Forecast Data
  • 10.3 Analysis by Distribution Channel
  • 10.4 Hospital Pharmacies Historic and Forecast Sales by Regions
  • 10.5 Retail Pharmacies Historic and Forecast Sales by Regions
  • 10.6 Online Pharmacies Historic and Forecast Sales by Regions

11 . GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET ANALYSIS BY GEOGRAPHY

  • 11.1. Top Company Share Analysis
  • 11.2. Introduction
  • 11.3. North America Sales Analysis
    • 11.3.1. Overview, Historic and Forecast Sales Analysis
    • 11.3.2. North America By Segment Sales Analysis
    • 11.3.3. North America By Country Sales Analysis
    • 11.3.4. United State Sales Analysis
    • 11.3.5. Canada Sales Analysis
    • 11.3.6. Mexico Sales Analysis
  • 11.4. Europe Sales Analysis
    • 11.4.1. Overview, Historic and Forecast Sales Analysis
    • 11.4.2. Europe by Segment Sales Analysis
    • 11.4.3. Europe by Country Sales Analysis
    • 11.4.4. United Kingdom Sales Analysis
    • 11.4.5. France Sales Analysis
    • 11.4.6. Germany Sales Analysis
    • 11.4.7. Italy Sales Analysis
    • 11.4.8. Russia Sales Analysis
    • 11.4.9. Rest Of Europe Sales Analysis
  • 11.5. Asia Pacific Sales Analysis
    • 11.5.1. Overview, Historic and Forecast Sales Analysis
    • 11.5.2. Asia Pacific by Segment Sales Analysis
    • 11.5.3. Asia Pacific by Country Sales Analysis
    • 11.5.4. China Sales Analysis
    • 11.5.5. India Sales Analysis
    • 11.5.6. Japan Sales Analysis
    • 11.5.7. South Korea Sales Analysis
    • 11.5.8. Australia Sales Analysis
    • 11.5.9. Rest Of Asia Pacific Sales Analysis
  • 11.6. Latin America Sales Analysis
    • 11.6.1. Overview, Historic and Forecast Sales Analysis
    • 11.6.2. Latin America by Segment Sales Analysis
    • 11.6.3. Latin America by Country Sales Analysis
    • 11.6.4. Brazil Sales Analysis
    • 11.6.5. Argentina Sales Analysis
    • 11.6.6. Peru Sales Analysis
    • 11.6.7. Chile Sales Analysis
    • 11.6.8. Rest of Latin America Sales Analysis
  • 11.7. Middle East & Africa Sales Analysis
    • 11.7.1. Overview, Historic and Forecast Sales Analysis
    • 11.7.2. Middle East & Africa by Segment Sales Analysis
    • 11.7.3. Middle East & Africa by Country Sales Analysis
    • 11.7.4. Saudi Arabia Sales Analysis
    • 11.7.5. UAE Sales Analysis
    • 11.7.6. Israel Sales Analysis
    • 11.7.7. South Africa Sales Analysis
    • 11.7.8. Rest Of Middle East And Africa Sales Analysis

12 . COMPETITIVE LANDSCAPE OF THE ORAL REHYDRATION SOLUTION (ORS) COMPANIES

  • 12.1. Oral Rehydration Solution (Ors) Market Competition
  • 12.2. Partnership/Collaboration/Agreement
  • 12.3. Merger And Acquisitions
  • 12.4. New Product Launch
  • 12.5. Other Developments

13 . COMPANY PROFILES OF ORAL REHYDRATION SOLUTION (ORS) INDUSTRY

  • 13.1. Company Share Analysis
  • 13.2. Market Concentration Rate
  • 13.3. FDC Limited
    • 13.3.1. Company Overview
    • 13.3.2. Company Revenue
    • 13.3.3. Products
    • 13.3.4. Recent Developments
  • 13.4. Cipla
    • 13.4.1. Company Overview
    • 13.4.2. Company Revenue
    • 13.4.3. Products
    • 13.4.4. Recent Developments
  • 13.5. Wallace Pharmaceuticals
    • 13.5.1. Company Overview
    • 13.5.2. Company Revenue
    • 13.5.3. Products
    • 13.5.4. Recent Developments
  • 13.6. Zydus Cadila Healthcare Ltd
    • 13.6.1. Company Overview
    • 13.6.2. Company Revenue
    • 13.6.3. Products
    • 13.6.4. Recent Developments
  • 13.7. Shereya Life Sciences
    • 13.7.1. Company Overview
    • 13.7.2. Company Revenue
    • 13.7.3. Products
    • 13.7.4. Recent Developments
  • 13.8. Mankind Pharma
    • 13.8.1. Company Overview
    • 13.8.2. Company Revenue
    • 13.8.3. Products
    • 13.8.4. Recent Developments
  • 13.9. Intas Pharmaceuticals Ltd.
    • 13.9.1. Company Overview
    • 13.9.2. Company Revenue
    • 13.9.3. Products
    • 13.9.4. Recent Developments
  • 13.10. Sun Pharma
    • 13.10.1. Company Overview
    • 13.10.2. Company Revenue
    • 13.10.3. Products
    • 13.10.4. Recent Developments
  • 13.11. Dr Reddy's
    • 13.11.1. Company Overview
    • 13.11.2. Company Revenue
    • 13.11.3. Products
    • 13.11.4. Recent Developments
  • 13.12. Alkem
    • 13.12.1. Company Overview
    • 13.12.2. Company Revenue
    • 13.12.3. Products
    • 13.12.4. Recent Developments
  • 13.13. Lupin
    • 13.13.1. Company Overview
    • 13.13.2. Company Revenue
    • 13.13.3. Products
    • 13.13.4. Recent Developments
  • 13.14. Cadila
    • 13.14.1. Company Overview
    • 13.14.2. Company Revenue
    • 13.14.3. Products
    • 13.14.4. Recent Developments
  • 13.15. RPG Life Sciences
    • 13.15.1. Company Overview
    • 13.15.2. Company Revenue
    • 13.15.3. Products
    • 13.15.4. Recent Developments
  • 13.16. Casca Remedies Pvt. Ltd.
    • 13.16.1. Company Overview
    • 13.16.2. Company Revenue
    • 13.16.3. Products
    • 13.16.4. Recent Developments
  • 13.17. Halewood Laboratories Pvt. Ltd.
    • 13.17.1. Company Overview
    • 13.17.2. Company Revenue
    • 13.17.3. Products
    • 13.17.4. Recent Developments
  • 13.18. Healthy Life Pharma Private Limited
    • 13.18.1. Company Overview
    • 13.18.2. Company Revenue
    • 13.18.3. Products
    • 13.18.4. Recent Developments
  • 13.19. Okasa Pharma Pvt. Ltd.
    • 13.19.1. Company Overview
    • 13.19.2. Company Revenue
    • 13.19.3. Products
    • 13.19.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Product Sales (USD MN)
  • OTC Products Market Sales by Geography (USD MN)
  • Prescription Market Sales by Geography (USD MN)
  • Analysis Market by Dosage Form (USD MN)
  • Powder Market Sales by Geography (USD MN)
  • Liquid Market Sales by Geography (USD MN)
  • Tablet Market Sales by Geography (USD MN)
  • Analysis by Customer Age (USD MN)
  • Children Market Sales by Geography (USD MN)
  • Adult Market Sales by Geography (USD MN)
  • Analysis by Indication (USD MN)
  • Diarrhea Market Sales by Geography (USD MN)
  • Gastroenteritis Market Sales by Geography (USD MN)
  • Electrolyte Imbalance Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales by Geography (USD MN)
  • Retail Pharmacies Market Sales by Geography (USD MN)
  • Online Pharmacies Market Sales by Geography (USD MN)
  • Global Oral Rehydration Solution (Ors) Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Oral Rehydration Solution (Ors) Report
  • Market Research Process
  • Market Research Methodology
  • Global Oral Rehydration Solution (Ors) Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product Sales
  • Market Attractiveness Analysis by Dosage Form
  • Market Attractiveness Analysis by Customer Age
  • Market Attractiveness Analysis by Indication
  • Market Attractiveness Analysis by Distribution Channel
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product Sales (USD MN)
  • OTC Products Market Sales by Geography (USD MN)
  • Prescription Market Sales by Geography (USD MN)
  • Global Market Analysis by Dosage Form (USD MN)
  • Powder Market Sales by Geography (USD MN)
  • Liquid Market Sales by Geography (USD MN)
  • Tablet Market Sales by Geography (USD MN)
  • Global Market Analysis by Customer Age (USD MN)
  • Children Market Sales by Geography (USD MN)
  • Adult Market Sales by Geography (USD MN)
  • Global Market Analysis by Indication (USD MN)
  • Diarrhea Market Sales by Geography (USD MN)
  • Gastroenteritis Market Sales by Geography (USD MN)
  • Electrolyte Imbalance Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales by Geography (USD MN)
  • Retail Pharmacies Market Sales by Geography (USD MN)
  • Online Pharmacies Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.